AN2 Therapeutics
Developing therapies for rare, chronic, and serious infectious diseases
35 employees · est. 2019 · Menlo Park, United States
Cormedix Inc. is the older company (2019 vs 2006); Cormedix Inc. is the larger of the two.
Side-by-Side Comparison
| Metric | AN2 Therapeutics | Cormedix Inc. |
|---|---|---|
| Founded | ||
| Founded | 2019 | 2006 older |
| Headquarters | ||
| Headquarters | Menlo Park, United States | United States |
| Employees | ||
| Employees | 35 | 93 larger |
| Industry | ||
| Industry | Biotechnology, Health Care, Pharmaceutical | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Grant | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $162.00M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 4 | Not tracked yet |
| Services | ||
| Services | Drug Discovery and Development, Clinical Trials, Research and Innovation in Boron Chemistry, Therapeutic Development for Infectious Diseases and Oncology | Not tracked yet |
| Target Customers | ||
| Target Customers | Healthcare Providers, Medical Research Institutions, Pharmaceutical Companies, Patients with Infectious Diseases, Oncology Patients | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Infectious Diseases, Drug Research, Boron Chemistry, Rare Diseases, Chronic Diseases, Global Health, Drug Development, Transformational Medicines, Biomedical Expertise, Medical Innovation, California-based Company, Industry Leaders | Not tracked yet |
| Website | ||
| Website | an2therapeutics.com | cormedix.com |
About AN2 Therapeutics
AN2 Therapeutics, founded in 2019, is a promising biopharmaceutical startup headquartered in the United States. The company is spearheading efforts in the biotechnology and healthcare sectors with its noteworthy focus on developing therapies for rare, chronic, and serious infectious diseases. The c...
About Cormedix Inc.
CorMedix Inc. is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company is focused on developing its lead product DefenCath™, a novel, antibacterial and antifungal solution des...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at AN2 Therapeutics and Cormedix Inc. — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at AN2 Therapeutics and Cormedix Inc. — by email.
Frequently Asked Questions
Compare AN2 Therapeutics with someone else
Start typing a company name or domain.